Have A Heart For Sickle Cell Anemia Foundation – Trademark Portfolio

Entity Type: 99

Have A Heart For Sickle Cell Anemia Foundation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. The owner is based in Chicago, IL.

47 West Polk Street, Suite 100-130

Chicago, IL 60605

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Have A Heart For Sickle Cell Anemia Foundation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (4 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Have A Heart For Sickle Cell Anemia Foundation have?

Have A Heart For Sickle Cell Anemia Foundation has 4 U.S. trademarks filed with the USPTO.

What trademark classes does Have A Heart For Sickle Cell Anemia Foundation file in?

Have A Heart For Sickle Cell Anemia Foundation files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What is Have A Heart For Sickle Cell Anemia Foundation's trademark registration success rate?

Have A Heart For Sickle Cell Anemia Foundation has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.